Current landscape, unmet needs, and future directions for treatment of bipolar depression

Journal of Affective Disorders

Volumn 169, Issue S1, 2014, Pages S17-S23

  Frye, Mark A ^a   Prieto, Miguel L ^b   Bobo, William V ^a   Kung, Simon ^a   Veldic, Marin ^a   Alarcon, Renato D ^a,c   Moore, Katherine M ^a   Choi, Doo Sup ^a,d   Biernacka, Joanna M ^a   Tye, Susannah J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

Antidepressants; Bipolar; Depression; Mood stabilizers

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; LURASIDONE; MOOD STABILIZER; OLANZAPINE; PAROXETINE; QUETIAPINE; VALPROATE SEMISODIUM; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; DRUG COMBINATION; FLUOXETINE; ISOINDOLE DERIVATIVE; THIAZOLE DERIVATIVE; TRIAZINE DERIVATIVE;

BIPOLAR DEPRESSION; COCHRANE LIBRARY; HUMAN; MEDLINE; PSYCHOTHERAPY; PSYCINFO; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; BIPOLAR DISORDER; DRUG COMBINATION; FORECASTING; HEALTH SERVICE;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG COMBINATIONS; FLUOXETINE; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; ISOINDOLES; PSYCHOTHERAPY; THIAZOLES; TRIAZINES;

EID: 84919627540     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/S0165-0327(14)70005-9     Document Type: Review

References (87)

1. Adler, C., Ketter, T., Frye, M.A., Yang, R., Bauer, M., 2014. Randomized, double-blind, placebo-controlled trial of adjunctive armodafinil (150 mg/day) in adults with bipolar I depression: Safety and primary efficacy findings. Presented at: 167th Annual Meeting of the American Psychiatric Association; May 3-7, 2014; New York, NY. Poster NR6-038.
2. K. Altinbas, A. Ozerdem, M.L. Prieto, M.E. Fuentes, N. Yalin, Z. Ersoy, O. Aydemir, D. Quiroz, S. Oztekin, J.R. Geske, S.E. Feeder, J. Angst, M.A. Frye A multinational study to pilot the modified Hypomania Checklist (mHCL) in the assessment of mixed depression J. Affect. Disord. 2014 152 154 478-482.
3. L.L. Altshuler, M.A. Frye, M.J. Gitlin Acceleration and augmentation strategies for treating bipolar depression Biol. Psychiatry 53 8 2003 691 700
4. L.L. Altshuler, M.J. Gitlin, J. Mintz, K.L. Leight, M.A. Frye Subsyndromal depression is associated with functional impairment in patients with bipolar disorder J. Clin. Psychiatry 63 9 2002 807 811
5. J.D. Amsterdam, J. Shults Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study Am. J. Psychiatry 167 7 2010 792 800
6. R.J. Baldessarini, L. Leahy, S. Arcona, D. Gause, W. Zhang, J. Hennen Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders Psychiatr. Serv. 58 1 2007 85 91
7. R.J. Baldessarini, J. Undurraga, G.H. Vazquez, L. Tondo, P. Salvatore, K. Ha, H.M. Khalsa, B. Lepri, T.H. Ha, J.S. Chang, M. Tohen, E. Vieta Predominant recurrence polarity among 928 adult international bipolar I disorder patients Acta Psychiatr. Scand. 125 4 2012 293 302
8. M. Berk, O.M. Dean, S.M. Cotton, C.S. Gama, F. Kapczinski, B. Fernandes, K. Kohlmann, S. Jeavons, K. Hewitt, K. Moss, C. Allwang, I. Schapkaitz, H. Cobb, A.I. Bush, S. Dodd, G.S. Malhi Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial BMC. Med. 10 2012 91
9. Z. Bhagwagar, G.M. Goodwin The role of lithium in the treatment of bipolar depression Clin. Neurosci. Res. 2 3 2002 222 227
10. J.M. Biernacka, S.L. McElroy, S. Crow, A. Sharp, J. Benitez, M. Veldic, S. Kung, J.M. Cunningham, R.M. Post, D. Mrazek, M.A. Frye Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association J. Affect. Disord. 136 1-2 2012 e21 e29
11. D.J. Bond, R.W. Lam, L.N. Yatham Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis J. Affect. Disord. 124 3 2010 228 234
12. C.L. Bowden, J.R. Calabrese, S.L. McElroy, L. Gyulai, A. Wassef, F. Petty, H.G. Pope Jr., J.C. Chou, P.E. Keck Jr., L.J. Rhodes, A.C. Swann, R.M. Hirschfeld, P.J. Wozniak, Divalproex Maintenance Study Group A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder Arch. Gen. Psychiatry 57 5 2000 481 489
13. B.P. Brennan, J.I. Hudson, J.E. Jensen, J. McCarthy, J.L. Roberts, A.P. Prescot, B.M. Cohen, H.G. Pope Jr., P.F. Renshaw, D. Ongur Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole Neuropsychopharmacology 35 3 2010 834 846
14. E. Brietzke, F. Kapczinski, R. Grassi-Oliveira, I. Grande, E. Vieta, R.S. McIntyre Insulin dysfunction and allostatic load in bipolar disorder Expert. Rev. Neurother. 11 7 2011 1017 1028
15. Calabrese JR, Frye MA, Yang R, Ketter TA; Armodafinil Treatment Trial Study Network, 2014. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial. J. Clin. Psychiatry, published online ahead of print July 22, 2014.
16. J.R. Calabrese, R.M. Hirschfeld, M.A. Frye, M.L. Reed Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample J. Clin. Psychiatry 65 11 2004 1499 1504
17. J.R. Calabrese, P.E. Keck Jr., W. Macfadden, M. Minkwitz, T.A. Ketter, R.H. Weisler, A.J. Cutler, R. McCoy, E. Wilson, J. Mullen, the BOLDER Study Group A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am. J. Psychiatry 162 7 2005 1351 1360
18. J.R. Calabrese, T.A. Ketter, J.M. Youakim, J.M. Tiller, R. Yang, M.A. Frye Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study J. Clin. Psychiatry 71 10 2010 1363 1370
19. A. Chiesa, F. Chierzi, R.D. De, A. Serretti Quetiapine for bipolar depression: a systematic review and meta-analysis Int. Clin. Psychopharmacol. 27 2 2012 76 90
20. A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown, S. Stockton, M. Purgato, L.M. Spineli, G.M. Goodwin, J.R. Geddes Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 9799 2011 1306 1315
21. B.N. Cuthbert, T.R. Insel Toward the future of psychiatric diagnosis: the seven pillars of RDoC BMC. Med. 11 2013 126
22. S. Dodd, M. Maes, G. Anderson, O.M. Dean, S. Moylan, M. Berk Putative neuroprotective agents in neuropsychiatric disorders Prog. Neuropsychopharmacol. Biol. Psychiatry 42 2013 135 145
23. A. Ferreira Ade, F.S. Neves, F.F. da Rocha, G.S. Silva, M.A. Romano-Silva, D.M. Miranda, M.L. De, H. Correa The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder J. Affect. Disord. 112 1-3 2009 267 272
24. K.N. Fountoulakis, E. Vieta Treatment of bipolar disorder: a systematic review of available data and clinical perspectives Int. J. Neuropsychopharmacol. 11 7 2008 999 1029
25. M.A. Frye Bipolar disorder - a focus on depression N. Engl. J. Med. 364 1 2011 51 59
26. M.A. Frye, K.D. Denicoff, A.L. Bryan, E.E. Smith-Jackson, S.O. Ali, D. Luckenbaugh, G.S. Leverich, R.M. Post Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients Am. J. Psychiatry 156 12 1999 1909 1914
27. M.A. Frye, K.A. Gary, L.B. Marangell, M.S. George, A.M. Callahan, J.T. Little, T. Huggins, G. Cora-Locatelli, E.A. Osuch, A. Winokur, R.M. Post CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression J. Neuropsychiatry Clin. Neurosci. 11 3 1999 349 353
28. M.A. Frye, H. Grunze, T. Suppes, S.L. McElroy, P.E. Keck Jr., J. Walden, G.S. Leverich, L.L. Altshuler, S. Nakelsky, S. Hwang, J. Mintz, R.M. Post A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression Am. J. Psychiatry 164 8 2007 1242 1249
29. M.A. Frye, G. Helleman, S.L. McElroy, L.L. Altshuler, D.O. Black, P.E. Keck Jr., W.A. Nolen, R. Kupka, G.S. Leverich, H. Grunze, J. Mintz, R.M. Post, T. Suppes Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression Am. J. Psychiatry 166 2 2009 164 172
30. M.A. Frye, T.A. Ketter, R. Yang Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder Bipolar Disord. 15 s1 2013 126 127
31. M.A. Frye, S.L. McElroy, M.L. Prieto, K.L. Harper, S. Kung, M. Chauhan, S. Crow, B. Sutor, C.W. Galardy, M. Veldic, B.A. Palmer, J.R. Geske, M. Fuentes, A.B. Cuellar-Barboza, L.R. Seymour, N. Mori, J.M. Biernacka Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania J. Clin. 2014 Psychiatry in press.
32. M.A. Frye, M.A. Thomas, K. Yue, N. Binesh, P. Davanzo, J. Ventura, J. O'Neill, B. Guze, J.G. Curran, J. Mintz Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy Psychiatry Res. 154 3 2007 259 265
33. M.A. Frye, L. Yatham, T.A. Ketter, J. Goldberg, T. Suppes, J.R. Calabrese, C.L. Bowden, E. Bourne, R.S. Bahn, B. Adams Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies Acta Psychiatr. Scand. 120 1 2009 10 13
34. J.R. Geddes, J.R. Calabrese, G.M. Goodwin Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials Br. J. Psychiatry 194 1 2009 4 9
35. J.F. Goldberg, K.E. Burdick, C.J. Endick Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression Am. J. Psychiatry 161 3 2004 564 566
36. F.K. Goodwin, K.R. Jamison Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression 2nd ed. 2007 Oxford University Press New York, NY
37. G.M. Goodwin, C.L. Bowden, J.R. Calabrese, H. Grunze, S. Kasper, R. White, P. Greene, R. Leadbetter A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder J. Clin. Psychiatry 65 3 2004 432 441
38. L. Gyulai, C.L. Bowden, S.L. McElroy, J.R. Calabrese, F. Petty, A.C. Swann, J.C. Chou, A. Wassef, C.S. Risch, R.M. Hirschfeld, C.B. Nemeroff, P.E. Keck Jr., D.L. Evans, P.J. Wozniak Maintenance efficacy of divalproex in the prevention of bipolar depression Neuropsychopharmacology 28 7 2003 1374 1382
39. L.L. Judd, H.S. Akiskal, P.J. Schettler, J. Endicott, J. Maser, D.A. Solomon, A.C. Leon, J.A. Rice, M.B. Keller The long-term natural history of the weekly symptomatic status of bipolar I disorder Arch. Gen. Psychiatry 59 6 2002 530 537
40. L.L. Judd, P.J. Schettler, H. Akiskal, W. Coryell, J. Fawcett, J.G. Fiedorowicz, D.A. Solomon, M.B. Keller Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes J. Affect. Disord. 138 3 2012 440 448
41. J.M. Kane Tardive dyskinesia circa 2006 Am. J. Psychiatry 163 8 2006 1316 1318
42. R.C. Kessler, H.S. Akiskal, M. Ames, H. Birnbaum, P. Greenberg, R.M. Hirschfeld, R. Jin, K.R. Merikangas, G.E. Simon, P.S. Wang Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers Am. J. Psychiatry 163 9 2006 1561 1568
43. M. Leboyer, I. Soreca, J. Scott, M. Frye, C. Henry, R. Tamouza, D.J. Kupfer Can bipolar disorder be viewed as a multi-system inflammatory disease? J. Affect. Disord. 141 1 2012 1 10
44. A. Loebel, J. Cucchiaro, R. Silva, H. Kroger, J. Hsu, K. Sarma, G. Sachs Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study Am. J. Psychiatry 171 2 2014 160 168
45. A. Loebel, J. Cucchiaro, R. Silva, H. Kroger, K. Sarma, J. Xu, J.R. Calabrese Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study Am. J. Psychiatry 171 2 2014 169 177
46. I. Lombardo, G. Sachs, S. Kolluri, C. Kremer, R. Yang Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? J. Clin. Psychopharmacol. 32 4 2012 470 478
47. L.B. Marangell, M.S. George, A.M. Callahan, T.A. Ketter, P.J. Pazzaglia, T.A. L'Herrou, G.S. Leverich, R.M. Post Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients Arch. Gen. Psychiatry 54 3 1997 214 222
48. L.B. Marangell, T.A. Ketter, M.S. George, P.J. Pazzaglia, A.M. Callahan, P. Parekh, P.J. Andreason, B. Horwitz, P. Herscovitch, R.M. Post Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders Am. J. Psychiatry 154 2 1997 224 230
49. E. Masoliver, A. Menoyo, V. Perez, V. Volpini, E.D. Rio, J. Perez, E. Alvarez, M. Baiget Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder Psychiatr. Genet. 16 1 2006 25 29
50. S.L. McElroy, R.H. Weisler, W. Chang, B. Olausson, B. Paulsson, M. Brecher, V. Agambaram, C. Merideth, A. Nordenhem, A.H. Young, EMBOLDEN II (Trial D1447C00134) Investigators A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II) J. Clin. Psychiatry 71 2 2010 163 174
51. E. Mundo, M. Walker, T. Cate, F. Macciardi, J.L. Kennedy The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings Arch. Gen. Psychiatry 58 6 2001 539 544
52. C.B. Nemeroff, D.L. Evans, L. Gyulai, G.S. Sachs, C.L. Bowden, I.P. Gergel, R. Oakes, C.D. Pitts Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression Am. J. Psychiatry 158 6 2001 906 912
53. F.G. Nery, E.S. Monkul, J.P. Hatch, M. Fonseca, G.B. Zunta-Soares, B.N. Frey, C.L. Bowden, J.C. Soares Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study Hum. Psychopharmacol. 23 2 2008 87 94
54. W.A. Nolen, R.H. Weisler The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144) Bipolar Disord. 15 1 2013 100 109
55. I. Pacchiarotti, D.J. Bond, R.J. Baldessarini, W.A. Nolen, H. Grunze, R.W. Licht, R.M. Post, M. Berk, G.M. Goodwin, G.S. Sachs, L. Tondo, R.L. Findling, E.A. Youngstrom, M. Tohen, J. Undurraga, A. Gonzalez-Pinto, J.F. Goldberg, A. Yildiz, L.L. Altshuler, J.R. Calabrese, P.B. Mitchell, M.E. Thase, A. Koukopoulos, F. Colom, M.A. Frye, G.S. Malhi, K.N. Fountoulakis, G. Vazquez, R.H. Perlis, T.A. Ketter, F. Cassidy, H. Akiskal, J.M. Azorin, M. Valenti, D.H. Mazzei, B. Lafer, T. Kato, L. Mazzarini, A. Martinez-Aran, G. Parker, D. Souery, A. Ozerdem, S.L. McElroy, P. Girardi, M. Bauer, L.N. Yatham, C.A. Zarate, A.A. Nierenberg, B. Birmaher, S. Kanba, R.S. El-Mallakh, A. Serretti, Z. Rihmer, A.H. Young, G.D. Kotzalidis, G.M. MacQueen, C.L. Bowden, S.N. Ghaemi, C. Lopez-Jaramillo, J. Rybakowski, K. Ha, G. Perugi, S. Kasper, J.D. Amsterdam, R.M. Hirschfeld, F. Kapczinski, E. Vieta The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders Am. J. Psychiatry 170 11 2013 1249 1262
56. M. Peet Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants Br. J. Psychiatry 164 4 1994 549 550
57. M.L. Phillips, D.J. Kupfer Bipolar disorder diagnosis: challenges and future directions Lancet 381 9878 2013 1663 1671
58. R.M. Post, L.L. Altshuler, G.S. Leverich, M.A. Frye, W.A. Nolen, R.W. Kupka, T. Suppes, S. McElroy, P.E. Keck, K.D. Denicoff, H. Grunze, J. Walden, C.M. Kitchen, J. Mintz Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline Br. J. Psychiatry 189 2006 124 131
59. M.L. Prieto, E.A. Youngstrom, A. Ozerdem, K. Altinbas, D. Quiroz, O. Aydemir, N. Yalin, J.R. Geske, S.E. Feedeer, J. Angst, M.A. Frye Different patterns of manic / hypomanic symptoms in depression: a pilot modification of the Hypomania Checklist - 32 to assess mixed depression J. Affect. Disord. 2014 In press.
60. A. Rousseva, C. Henry, D. van den Bulke, G. Fournier, J.L. Laplanche, M. Leboyer, F. Bellivier, J.M. Aubry, P. Baud, M. Boucherie, C. Buresi, F. Ferrero, A. Malafosse Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism Pharmacogenomics J. 3 2 2003 101 104
61. A.J. Rush, D.E. Giles, M.A. Schlesser, C.L. Fulton, J. Weissenburger, C. Burns The Inventory for Depressive Symptomatology (IDS): preliminary findings Psychiatry Res. 18 1 1986 65 87
62. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, M.H. Trivedi The Inventory of Depressive Symptomatology (IDS): psychometric properties Psychol. Med. 26 3 1996 477 486
63. G.S. Sachs, K.S. Ice, P.B. Chappell, J.H. Schwartz, O. Gurtovaya, D.G. Vanderburg, B. Kasuba Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial J. Clin. Psychiatry 72 10 2011 1413 1422
64. G.S. Sachs, A.A. Nierenberg, J.R. Calabrese, L.B. Marangell, S.R. Wisniewski, L. Gyulai, E.S. Friedman, C.L. Bowden, M.D. Fossey, M.J. Ostacher, T.A. Ketter, J. Patel, P. Hauser, D. Rapport, J.M. Martinez, M.H. Allen, D.J. Miklowitz, M.W. Otto, E.B. Dennehy, M.E. Thase Effectiveness of adjunctive antidepressant treatment for bipolar depression N. Engl. J. Med. 356 17 2007 1711 1722
65. A. Serretti, P. Artioli, R. Zanardi, C. Lorenzi, D. Rossini, C. Cusin, A. Arnoldi, M. Catalano Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder Psychopharmacology (Berl.) 174 4 2004 504 511
66. M.M. Sidor, G.M. MacQueen An update on antidepressant use in bipolar depression Curr. Psychiatry Rep. 14 6 2012 696 704
67. M.M. Sidor, G.M. MacQueen Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis J. Clin. Psychiatry 72 2 2011 156 167
68. E. Smeraldi, F. Benedetti, B. Barbini, E. Campori, C. Colombo Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial Neuropsychopharmacology 20 4 1999 380 385
69. L.A. Smith, V.R. Cornelius, J.M. Azorin, G. Perugi, E. Vieta, A.H. Young, C.L. Bowden Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis J. Affect. Disord. 122 1-2 2010 1 9
70. D.A. Solomon, A.C. Leon, W.H. Coryell, J. Endicott, C. Li, J.G. Fiedorowicz, L. Boyken, M.B. Keller Longitudinal course of bipolar I disorder: duration of mood episodes Arch. Gen. Psychiatry 67 4 2010 339 347
71. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, W. Nolen Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res. 73 3 1997 159 171
72. S.M. Strakowski, C.M. Adler, J. Almeida, L.L. Altshuler, H.P. Blumberg, K.D. Chang, M.P. DelBello, S. Frangou, A. McIntosh, M.L. Phillips, J.E. Sussman, J.D. Townsend The functional neuroanatomy of bipolar disorder: a consensus model Bipolar Disord. 14 4 2012 313 325
73. T. Suppes, C. Datto, M. Minkwitz, A. Nordenhem, C. Walker, D. Darko Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression J. Affect. Disord. 121 1-2 2010 106 115
74. M.P. Szuba, L.R. Baxter Jr., L.L. Altshuler, E.M. Allen, B.H. Guze, J.M. Schwartz, E.H. Liston Lithium sustains the acute antidepressant effects of sleep deprivation: preliminary findings from a controlled study Psychiatry Res. 51 3 1994 283 295
75. M.E. Thase, A. Jonas, A. Khan, C.L. Bowden, X. Wu, R.D. McQuade, W.H. Carson, R.N. Marcus, R. Owen Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies J. Clin. Psychopharmacol. 28 1 2008 13 20
76. M.E. Thase, W. Macfadden, R.H. Weisler, W. Chang, B. Paulsson, A. Khan, J.R. Calabrese, BOLDER II Study Group Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) J. Clin. Psychopharmacol. 26 6 2006 600 609
77. M. Tohen, H. Katagiri, S. Fujikoshi, S. Kanba Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies J. Affect. Disord. 149 1-3 2013 196 201
78. M. Tohen, D.P. McDonnell, M. Case, S. Kanba, K. Ha, Y.R. Fang, H. Katagiri, J.C. Gomez Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression Br. J. Psychiatry 201 5 2012 376 382
79. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, P.B. Mitchell, F. Centorrino, R. Risser, R.W. Baker, A.R. Evans, K. Beymer, S. Dubé, G.D. Tollefson, A. Breier Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Arch. Gen. Psychiatry 60 11 2003 1079 1088
80. S.J. Tye Allostatic overload: transcriptomic insights into the molecular basis of antidepressant resistance Bipolar Disord. 15 Suppl 1 2013 41
81. M.L. van der Loos, P.G. Mulder, E.G. Hartong, M.B. Blom, A.C. Vergouwen, H.J. de Keyzer, P.J. Notten, M.L. Luteijn, M.A. Timmermans, E. Vieta, W.A. Nolen Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial J. Clin. Psychiatry 70 2 2009 223 231
82. E. Vieta, A. Martinez-Aran, J.M. Goikolea, C. Torrent, F. Colom, A. Benabarre, M. Reinares A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers J. Clin. Psychiatry 63 6 2002 508 512
83. World Health Organization The global burden of disease: 2004 update 2008 World Health Organization Geneva, Switzerland http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full.pdf Accessed October 17, 2014.
84. A.H. Young, S.L. McElroy, M. Bauer, N. Philips, W. Chang, B. Olausson, B. Paulsson, M. Brecher, for the EMBOLDEN I (Trial 001) Investigators A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I) J. Clin. Psychiatry 71 2 2010 150 162
85. C.A. Zarate Jr., N.E. Brutsche, L. Ibrahim, J. Franco-Chaves, N. Diazgranados, A. Cravchik, J. Selter, C.A. Marquardt, V. Liberty, D.A. Luckenbaugh Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol. Psychiatry 71 11 2012 939 946
86. C.A. Zarate Jr., J.L. Payne, J. Singh, J.A. Quiroz, D.A. Luckenbaugh, K.D. Denicoff, D.S. Charney, H.K. Manji Pramipexole for bipolar II depression: a placebo-controlled proof of concept study Biol. Psychiatry 56 1 2004 54 60
87. C.A. Zarate Jr., J.A. Quiroz, J.B. Singh, K.D. Denicoff, J.G. De, D.A. Luckenbaugh, D.S. Charney, H.K. Manji An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression Biol. Psychiatry 57 4 2005 430 432